Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting PORTLAND, Ore., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Aronora Inc., a clinical-stage biotechnology company developing next-generation therapeutics for blood clotting diseases, announced today that...